Economic Impact of Reducing Hospital Admissions for Patients Presenting to the Emergency Department With Worsening Heart Failure: An Adaptive Clinical Trial of Furoscix Infusor
Latest Information Update: 24 Aug 2023
Price :
$35 *
At a glance
- Drugs Furosemide (Primary) ; Furosemide
- Indications Heart failure
- Focus Registrational; Therapeutic Use
- Acronyms FREEDOM-HF
- Sponsors scPharmaceuticals
- 10 Aug 2023 According to scPharmaceuticals Media Release, the company announced that results from the FREEDOM-HF study have been accepted for publication in the peer-reviewed journal Future Cardiology.
- 10 May 2023 According to a scPharmaceuticals media release, data from this study were presented at the Technology and Heart Failure Therapeutics Conference 2023.
- 22 Mar 2023 According to a scPharmaceuticals media release, data from this study will be presented at the Technology and Heart Failure Therapeutics Conference, March 20-22, 2023.